Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
It remains controversial whether papillary thyroid cancer (PTC) patients with low- to intermediate-risk disease should receive radioactive iodine (RAI) after total thyroidectomy (TT). We aim to identify those who might benefit from RAI treatment in PTC patients with cervical nodal metastasis after T...
Main Authors: | Hengqiang Zhao, Yiping Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.960682/full |
Similar Items
-
Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma
by: Hengqiang Zhao, et al.
Published: (2021-06-01) -
Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
by: Jonghwa Ahn, et al.
Published: (2020-03-01) -
Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
by: Lina Liu, et al.
Published: (2022-05-01) -
Analysis of tumor recurrence factors of the patients with intermediate risk papillary thyroid carcinoma after radioactive iodine treatment
by: TANG Linglin, LI Li, LAI Yi, LIU Jianjun, ZHOU Xiang
Published: (2023-11-01) -
Efficacy of Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma: Propensity Scoring Matching
by: Byung Joon Yoo, et al.
Published: (2019-03-01)